Krishnaswamy Yeleswaram sold $303K of Rapport Therapeutics (RAPP)

Executed Mar 25, disclosed Mar 26, 1 day later.

Value, as filed

$303K

10,115 sh × $29.99

Executed

Mar 25

the trade date, as filed

Disclosed

Mar 26

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Krishnaswamy Yeleswaram Chief Development Officer profile →

Krishnaswamy Yeleswaram (Chief Development Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $2.5M of RAPP (50,160 sh across 3 lots, as filed), executed Aug 24.

The name

RAPP

Rapport Therapeutics, Inc. RAPP · Healthcare · 38 filings in 24 months ticker →

Healthcare · Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transfo…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Krishnaswamy Yeleswaram in RAPP

RAPPSALE Rapport Therapeutics, Inc. $2.5M
50,160 sh across 3 lots
Exec Aug 24
Filed Aug 26 · 4:00 PM ET RAPPSALE Rapport Therapeutics, Inc. $809K
20,225 sh × $39.99
Exec Apr 17
Filed Apr 21 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. $678K
19,365 sh across 2 lots
Exec Apr 13
Filed Apr 14 · 5:30 PM ET